Jazz Pharmaceuticals Plc · NASDAQ:JAZZ

Smith Mark Douglas received 1,605 Jazz Pharmaceuticals Plc shares as an award (Form 4)

Traded Aug 5, 2026 · Filed Aug 7, 2026

On Aug 5, 2026, Smith Mark Douglas (Director) received 1,605 Jazz Pharmaceuticals Plc shares as an award, leaving 11,285 shares. Filed Aug 7, 2026 (Form 4).

Awarded
1,605 shares
Holding after
11,285 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 5, 2026Ordinary SharesAward1,60511,285Direct

Source

View original at SEC

Related